Concord Biotech Limited (CONCORDBIO.BO)
INR 1719.65
(-1.27%)
INR 1719.65
(-1.27%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 17 Billion INR | 12.33% |
| 2022 | 15.13 Billion INR | 15.33% |
| 2021 | 13.12 Billion INR | 11.01% |
| 2020 | 11.82 Billion INR | 25.73% |
| 2019 | 9.4 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 17 Billion INR | 0.0% |
| 2023 Q2 | 15.51 Billion INR | 0.0% |
| 2023 FY | 17 Billion INR | 12.33% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | 0.0% |
| 2022 FY | 15.13 Billion INR | 15.33% |
| 2022 Q4 | 15.13 Billion INR | 0.0% |
| 2021 FY | 13.12 Billion INR | 11.01% |
| 2020 FY | 11.82 Billion INR | 25.73% |
| 2019 FY | 9.4 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.78 Billion INR | -852.45% |
| Biocon Limited | 560.7 Billion INR | 96.967% |
| Blue Jet Healthcare Limited | 10.58 Billion INR | -60.619% |
| Dishman Carbogen Amcis Limited | 95.81 Billion INR | 82.25% |
| FERMENTA BIOTECH LIMITED | 5.47 Billion INR | -210.444% |
| GENOMIC VALLEY BIOTECH LIMITED | 43.33 Million INR | -39144.049% |
| Lyka Labs Limited | 1.56 Billion INR | -985.159% |
| Panacea Biotec Limited | 12.4 Billion INR | -37.079% |
| SAMSRITA LABS LIMITED | 155.51 Million INR | -10836.118% |
| Servoteach Industries Limited | 1591.00 INR | -1068955588.246% |
| SMS Lifesciences India Limited | 3.9 Billion INR | -335.499% |
| Supriya Lifescience Limited | 9.21 Billion INR | -84.611% |
| Syngene International Limited | 61.51 Billion INR | 72.353% |
| TAKE Solutions Limited | 881.05 Million INR | -1830.32% |
| Titan Biotech Limited | 1.56 Billion INR | -986.16% |
| Transgene Biotek Limited | 324.4 Million INR | -5142.579% |
| Vanta Bioscience Limited | 853.96 Million INR | -1891.541% |